Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Long-Term Investments (2025 - 2026)

Updated

Drugs Made In America Acquisition (DMII) reported Long-Term Investments of $513.88 million for Q2 2026.

Analysis

Drugs Made In America Acquisition (DMII) Long-Term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition posted Long-Term Investments of $504.93 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 15.14 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 34.59 Bn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 58.52 Bn
5 Kkr 81.05 Bn 47.53 Bn - 316.77 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 10.36 Bn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 333.84 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 147.62 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 1.22 Bn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - 513.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 513.88 Mn
Dec 31, 2025 504.93 Mn
Sep 30, 2025 500.11 Mn
API Access

Drugs Made In America Acquisition Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=DMII&period=max&api_key=YOUR_API_KEY